NMN for Hyperlipidemia: What the Evidence Actually Shows
What is Hyperlipidemia?
Hyperlipidemia means elevated blood lipids, usually LDL cholesterol or triglycerides. It is a major driver of atherosclerosis and cardiovascular events.
NMN relevance: the published evidence
No human trial has shown that NMN lowers LDL or triglycerides meaningfully. Some small Japanese studies (Irie 2020) measured lipid panels as safety endpoints, with no clinically relevant change. NMN is not a lipid-lowering agent and cannot replace statins or lifestyle therapy.
Questions to ask before supplementing
No dose validated for lipid-lowering.
Contraindications and red flags
Continue prescribed statin therapy; do not stop based on supplement use.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have hyperlipidemia, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Atherosclerosis - Atherosclerosis is the build-up of plaque in arteries, narrowing blood flow and triggering heart att...
- Ischemic Heart Disease - Ischemic heart disease is reduced blood flow to the heart muscle, usually from coronary atherosclero...
- Metabolic Syndrome - Metabolic syndrome is a cluster of conditions including central obesity, high blood pressure, dyslip...
- Non-Alcoholic Fatty Liver Disease - NAFLD is fat accumulation in the liver unrelated to alcohol, often tied to obesity and insulin resis...